Navigation Links
Stem Cells Market is Expected to Reach USD 119.51 Billion Globally in 2018: Transparency Market Research
Date:6/25/2013

ALBANY, New York, June 25, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market for stem cells was valued at USD 26.23 billion in 2011 and is expected to reach an estimated value of USD 119.51 billion in 2018, growing at a CAGR of 24.2% from 2012 to 2018.

Browse the full report at  http://www.transparencymarketresearch.com/stem-cells-market.html

The market growth is majorly attributed to therapeutic research activities led by government support worldwide owing to the growing number of patients with chronic diseases across the globe. In addition, rising awareness of regenerative treatment options and growing importance of stem cell banking services are also fostering the growth of the market. Apart from these, development of medical tourism hubs in developing nations such as India and China and in turn migration of patients from developed nations such as the U.S., and Europe for quality treatment at significantly lower prices will also serve the market as a driver especially for the Asian stem cells market.

Stem cells market will be driven by rising proportion of patients with neurological and other chronic conditions and rising disposable incomes of patients induced by economic growth of Asian regions in the next five years In addition, increasing dependence on stem cells for drug discovery and screening will boost the growth of the market in future. Increased outsourcing of contract research and clinical trials to developing Asian regions will further encourage growth of the stem cells market.

Adult stem cells held majority share of the overall stem cells market in 2011 at over 80%. This is due to less laborious procedure of harvesting, and less probability of contamination during expansion and sub-culture of adult stem cells. However, fewer post-transplant complications and lesser risk of graft vs. host reaction from the recently introduced induced pluripotent stem cells will lead to its rapid inclusion in research activities and help the global induced pluripotent stem cells market to grow at a relatively faster CAGR during the forecast period.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/coronary-stents-market.html

http://www.transparencymarketresearch.com/weight-management-market.html

http://www.transparencymarketresearch.com/magnetic-resonance-imaging-market.html

http://www.transparencymarketresearch.com/ultrasound-market.html

http://www.transparencymarketresearch.com/computed-tomography-market.html

Regenerative medicine dominated the stem cells market by applications in 2011, and is expected to maintain its leading position till 2018. Considerable research activities and the resultant developed therapies in neurology will drive the stem cells market in the forecast period.

North America was the market leader of the total stem cells market in 2011 and is expected to maintain its leading position till 2018. North American market is a center for stem cells research owing to greater support offered by federal government, and higher affordability of treatment in the region. High prevalence of chronic diseases in the region and support in terms of funding from government and private organizations is driving the European stem cells market.

The key players in stem cell research and technology include Advanced Cell Technology Inc., Stem Cell Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., and Cellartis Ab among others.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/catheters-market.html

http://www.transparencymarketresearch.com/spectrometry-market.html

http://www.transparencymarketresearch.com/chromatography-market.html

http://www.transparencymarketresearch.com/asia-pacific-endoscopy-devices-market.html

http://www.transparencymarketresearch.com/global-array-market.html

The global stem cells market is categorized into the following segments:

  • Stem Cells Market by Products
    • Adult Stem Cells
      • Hematopoietic Stem Cells
      • Mesenchymal Stem Cells
      • Neuronal Stem Cells
      • Dental Stem Cells
      • Umbilical Cord Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic-Like Stem Cells
  • Stem Cells Market by Technology
    • Cell Acquisition
      • Bone Marrow Harvest
      • Apheresis
      • Umbilical Cord Blood
    • Cell Production
      • Therapeutic Cloning
      • In Vitro Fertilization
      • Isolation
      • Cell Culture
    • Cryopreservation
    • Expansion and Sub-Culture
  • Stem Cells Market by Applications
    • Regenerative Medicine
      • Neurological Disorders
      • Orthopedics
      • Cancer
      • Hematological disorders
      • Cardiovascular diseases
      • Injuries
        • Wound Care
        • Spinal Cord Injury
        • Others (Joint Injuries, Eye Injuries, Lacerations and Concussions)
      • Diabetes
      • Liver Disorder
      • Incontinence
      • Others (Crohn's Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
    • Drug Discovery and Development
  • Stem Cells Market by Geography
    • North America
    • Europe
    • Asia

      Rest of the World (RoW)

Browse all Medical Devices Market Research Reports@ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html 

Upcoming Reports in Medical Devices Market

PreClinical Imaging Market

Medical Plastics Market

Apheresis Market

X-Ray Market

Medical Bionic Implant Market

Medical Aesthetics Market

Orthopedics Market

Microelectronic Medical Implants Market

E-Prescribing Market

Ophthalmology Devices Market

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact: Sheela AK, 90 Sate Street, Suite 700, Albany, NY 12207, Tel: +1-518-618-1030, USA - Canada Toll Free: 866-552-3453, Email: sales@transparencymarketresearch.com

Visit: http://de.transparencymarketresearch.com/

Visit: http://www.europlat.org/

Visit: http://businessresearchindustry.blogspot.com/

Visit: http://www.transparencymarketresearch.com/


'/>"/>
SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. US and Canadian researchers drive towards cheaper fuel cells for electric cars
2. Stem Cells May Help Some With Avascular Necrosis (AVN)
3. BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004)
4. Lisa Lorraine Reyes Muñoz, GeneCell International’s Physician Relation's Manager Launches Educational Meetings for General Public on Umbilical Cord Blood Stem Cells
5. The Alliance for the Advancement of Adult Stem Cell Therapy and Research Recently Has Proven Stem Cells To Be Effective in Dilated Cardiomyopathy
6. NYSCF scientists create personalized bone substitutes from skin cells
7. Adult cells transformed into early-stage nerve cells, bypassing the pluripotent stem cell stage
8. Stemedica Issued U.S. Patent For Ectodermal Stem Cells
9. No rebirth for insulin secreting pancreatic beta cells
10. Scripps Research Institute Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
11. Scientists Find Way to Fast-Track Production of Stem Cells that Show Promise in Treating AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal ... its proprietary NeXosome® technology for early warning of ... its most recent study by Dr. Thomas ... the Society for Maternal Fetal Medicine,s (SMFM) annual meeting ... 1-6 th , 2016.  The presentation reported initial ...
(Date:2/10/2016)... 10, 2016  Matchbook, Inc., a company specializing ... biotech companies, announced today the appointment of ... Jim brings nearly 25 years of experience in ... spent nearly two decades in executive level roles ... at Genzyme and, most recently headed global logistics ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces that ... secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment goals ... study, which seeks to advance understanding of the hereditary risks for certain kinds ...
(Date:2/9/2016)... ... February 09, 2016 , ... With a presidential election in ... Care Business Conference will bring together over 500 top healthcare leaders for a night ... transformation. The conference, organized by MBA students of the University of Pennsylvania’s Wharton School, ...
Breaking Biology Technology:
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... Va. , Feb. 2, 2016   ... award from the U.S. Army Research Office and ... the range and sensitivity of the company,s ... Past Accounting Mission and, more generally, defense-related DNA ... DNA phenotyping capabilities (predicting appearance and ancestry from ...
(Date:1/28/2016)... 2016 Synaptics (NASDAQ: SYNA ), a leading developer ... quarter ended December 31, 2015. --> ... 2016 increased 2 percent compared to the comparable quarter last year ... 2016 was $35.0 million, or $0.93 per diluted share. ... the first quarter of fiscal 2016 grew 9 percent over the ...
Breaking Biology News(10 mins):